coming soon


As of today, effective and safe treatment of bacterial endocarditis remains one of the last unmet medical needs in cardiology. devie medical transforms the treatment of bacterial endocarditis with an evolutionary transcatheter platform for drug delivery. By merging cutting edge medical technology with a proprietary pharmacological concept, we are not only defining the next frontier in an emerging therapeutic area, but pushing the boundaries for cardiovascular interventions.

For updates, please follow us on LinkedIn


devie medical GmbH
c/o Universitätsklinikum

Bachstraße 18
07743 Jena

Telefon: +49 3641 637 43 81
E-Mail: info@deviemedical.com

Geschäftsführer/Managing Director:
Prof. Dr. Hans-Reiner Figulla

Handelsregisternummer/Commercial Register Number:
Amtsgericht Jena HRB 514332 
USt.-IdNr./VAT-ID: DE 317907544